Get the Stockscreener App
6.91
3.44%
0.23
After Hours:
7.00
0.09
+1.30%
Alpha Cognition Inc stock is traded at $6.91, with a volume of 25,621.
It is up +3.44% in the last 24 hours and up +20.17% over the past month.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
See More
Previous Close:
$6.68
Open:
$6.72
24h Volume:
25,621
Relative Volume:
0.54
Market Cap:
$150.46M
Revenue:
$10.83M
Net Income/Loss:
$-25.14M
P/E Ratio:
-5.035
EPS:
-1.3724
Net Cash Flow:
$-30.41M
1W Performance:
+14.40%
1M Performance:
+20.17%
6M Performance:
+36.83%
1Y Performance:
-22.66%
1-Day Range:
$6.1174
$7.03
1-Week Range:
$5.85
$7.03
52-Week Range:
$4.50
$11.54
Alpha Cognition Inc Stock (ACOG) Company Profile
Name
Alpha Cognition Inc
Sector
Industry
Phone
(858) 344-4375
Address
1452 HUGHES RD., STE. 200, GRAPEVINE
Compare ACOG vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACOG
Alpha Cognition Inc
|
6.91 | 145.45M | 10.83M | -25.14M | -30.41M | -1.3724 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 116.49B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.73B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 55.49B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.75B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 33.54B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-26 | Initiated | Craig Hallum | Buy |
| Mar-18-25 | Initiated | H.C. Wainwright | Buy |
Alpha Cognition Inc Stock (ACOG) Latest News
Alpha Cognition Insiders Still US$88k Away From Original Investment Value - simplywall.st
Alpha Cognition Inc (ACOG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Alpha Cognition Inc (ACOG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Alpha Cognition Inc (ACOG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alpha Cognition Inc (ACOG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Alpha Cognition Inc (ACOG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Alpha Cognition (ACOG) Launches RESOLVE Study for ZUNVEYL Evalua - GuruFocus
Alpha Cognition enrolls first patient in ZUNVEYL phase 4 study - Investing.com
Alzheimer’s drug ZUNVEYL to be tested in real-world use through Q2 2027 - Stock Titan
Alpha Cognition Inc (ACOG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Alpha Cognition (ACOG) Slips Modestly, Support Level Tested AgainVolume Rate Change - newsline.com
ACOG Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
We Think Alpha Cognition (NASDAQ:ACOG) Needs To Drive Business Growth Carefully - Yahoo Finance
ACOG Q1 2026 Earnings: EPS Surpasses Estimates Amidst Revenue UncertaintyLong-Term Guidance - newsline.com
ACOG Technical Analysis & Stock Price Forecast - Intellectia AI
Major Investor Quietly Boosts Stake in Alpha Cognition With Fresh Buy-In - TipRanks
Alpha Cognition (ACOG) 10K Form and Latest SEC Filings 2026 - MarketBeat
Alpha Cognition (ACOG) Slips Slightly as It Tests Key Support LevelsShort Term Trading Ideas - newsline.com
Major Investor Quietly Boosts Stake in Alpha Cognition Inc. With Fresh Buy - TipRanks
Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease - BioSpace
ACOG Q1 2026 Earnings: EPS Beat on Narrower Loss; Still No RevenueEarnings Whisper Number - newsline.com
Alpha Cognition Reports Positive Top-Line Results Of Zunveyl® In Alzheimer’s Disease - TradingView
ALPHA COGNITION INC (ACOG) Stock Chart - ChartMill
Alpha Cognition Inc. (ACOG) Slips 2.37%: Support and Resistance Levels in FocusGamma Flip Level - newsline.com
Alpha Cognition Inc. (ACOG) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive SentimentMargin Compression Risk - newsline.com
Alpha Cognition Inc. Q1 2026 Earnings: Narrowed Loss Beats Estimates as Clinical Pipeline AdvancesEarnings Trend Analysis - newsline.com
ACOGAlpha Cognition Inc. stock news, filings & ratings - Quantisnow
Major Investor Quietly Boosts Stake in Alpha Cognition Inc. in Fresh Buying Spree - TipRanks
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Alpha Cognition (ACOG) Receives Buy Rating with $12 Price Target - GuruFocus
Alpha Cognition Initiated at Buy by Maxim Group - Moomoo
ACOG Initiates Coverage On by Maxim Group -- Rating Set to Buy - GuruFocus
Maxim Initiates Alpha Cognition at Buy With $12 Price Target - marketscreener.com
Alpha Cognition Inc. (ACOG) Surges 4.2%: Biotech Momentum Builds Near Key ResistanceReversal Setup Alerts - newsline.com
Alpha Cognition Inc. (ACOG) Edges Lower Amid Selling Pressure – Key Support in FocusLong Setup Ideas - The Legal Advocate
Alpha Cognition Inc. (ACOG) Edges Higher as Price Consolidates Near Key ResistancePut Dominated - The Legal Advocate
Alpha Cognition Inc. (ACOG) Edges Higher as Stock Holds Above Key SupportChange of Character - The Legal Advocate
Alpha Cognition Q1 earnings call highlights - MSN
Alpha Cognition Inc. Q1 2026 Earnings: Narrowed Loss Beats Expectations Amid Clinical ProgressInstitutional Grade Picks - Newser
Major Investor Quietly Ramps Up Position in Alpha Cognition Inc. Stock - TipRanks
Alpha Cognition Maintained at Buy as ZUNVEYL Outperforms Expectations; $18 Price Target Reiterated - TipRanks
ACOG Reiterates by HC Wainwright & Co. -- Price Target Maintained at $18 - GuruFocus
H.C. Wainwright Maintains Alpha Cognition(ACOG.US) With Buy Rating, Maintains Target Price $18 - Moomoo
Alpha Cognition Charts Aggressive Path After Earnings Call - The Globe and Mail
ACOG: COO D’Angelo Lauren Buys 3,500 Shares May 20, 2026 - Meyka
Insiders Double Down on Alpha Cognition as Big Money Moves In - TipRanks
Why Is Alpha Cognition Inc. (ACOGF) Stock Down Today? - Meyka
Alpha Cognition Inc. (ACOG) reports Q1 loss, tops revenue estimates - MSN
Alpha Cognition Inc. (NASDAQ:ACOG) Just Reported, And Analysts Assigned A US$16.00 Price Target - Yahoo Finance
Alpha Cognition Inc. Common Stock Q1 2026 Earnings Call Summary - Yahoo Finance
Alpha Cognition Inc Stock (ACOG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):